IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,737 | -56.9% | 1,738 | -52.3% | 0.00% | – |
| Q2 2023 | $38,803 | +43.0% | 3,647 | +41.4% | 0.00% | – |
| Q1 2023 | $27,141 | -27.2% | 2,580 | -14.3% | 0.00% | – |
| Q4 2022 | $37,306 | -67.3% | 3,011 | -72.5% | 0.00% | – |
| Q3 2022 | $114,000 | -59.7% | 10,952 | -55.3% | 0.00% | – |
| Q2 2022 | $283,000 | -45.4% | 24,477 | -40.7% | 0.00% | – |
| Q1 2022 | $518,000 | +14.6% | 41,253 | +6.2% | 0.00% | – |
| Q4 2021 | $452,000 | -11.2% | 38,851 | -0.1% | 0.00% | – |
| Q3 2021 | $509,000 | +41.0% | 38,888 | +39.2% | 0.00% | – |
| Q2 2021 | $361,000 | -0.8% | 27,939 | -14.2% | 0.00% | – |
| Q1 2021 | $364,000 | -21.2% | 32,568 | -19.9% | 0.00% | – |
| Q4 2020 | $462,000 | +8.5% | 40,648 | -14.4% | 0.00% | -100.0% |
| Q3 2020 | $426,000 | +1.7% | 47,488 | +17.0% | 0.00% | 0.0% |
| Q2 2020 | $419,000 | -4.1% | 40,604 | -6.4% | 0.00% | 0.0% |
| Q1 2020 | $437,000 | +5.3% | 43,400 | +39.4% | 0.00% | – |
| Q4 2019 | $415,000 | +49.3% | 31,144 | -4.0% | 0.00% | – |
| Q3 2019 | $278,000 | -19.4% | 32,444 | +3.0% | 0.00% | – |
| Q2 2019 | $345,000 | +8.2% | 31,488 | +33.6% | 0.00% | – |
| Q1 2019 | $319,000 | +27.6% | 23,562 | -2.2% | 0.00% | – |
| Q4 2018 | $250,000 | -88.4% | 24,084 | -79.3% | 0.00% | -100.0% |
| Q3 2018 | $2,152,000 | +562.2% | 116,489 | +584.7% | 0.00% | – |
| Q2 2018 | $325,000 | +32400.0% | 17,013 | +17621.9% | 0.00% | – |
| Q1 2018 | $1,000 | -100.0% | 96 | -100.0% | 0.00% | -100.0% |
| Q4 2017 | $3,514,000 | -22.7% | 234,446 | -18.7% | 0.00% | -40.0% |
| Q3 2017 | $4,548,000 | -8.7% | 288,458 | +9.3% | 0.01% | 0.0% |
| Q2 2017 | $4,982,000 | +12.4% | 263,899 | +1.5% | 0.01% | 0.0% |
| Q1 2017 | $4,433,000 | +24.1% | 259,885 | +11.2% | 0.01% | +25.0% |
| Q4 2016 | $3,573,000 | +45.8% | 233,715 | +51.6% | 0.00% | +33.3% |
| Q3 2016 | $2,450,000 | +33.8% | 154,213 | +10.1% | 0.00% | +50.0% |
| Q2 2016 | $1,831,000 | +22787.5% | 140,057 | +20227.6% | 0.00% | – |
| Q1 2016 | $8,000 | -61.9% | 689 | -61.9% | 0.00% | – |
| Q4 2015 | $21,000 | +10.5% | 1,807 | 0.0% | 0.00% | – |
| Q3 2015 | $19,000 | -17.4% | 1,807 | -2.3% | 0.00% | – |
| Q2 2015 | $23,000 | -8.0% | 1,849 | +18.9% | 0.00% | – |
| Q1 2015 | $25,000 | +8.7% | 1,555 | 0.0% | 0.00% | – |
| Q4 2014 | $23,000 | -25.8% | 1,555 | -33.8% | 0.00% | – |
| Q3 2014 | $31,000 | -11.4% | 2,349 | 0.0% | 0.00% | – |
| Q2 2014 | $35,000 | +483.3% | 2,349 | +389.4% | 0.00% | – |
| Q1 2014 | $6,000 | +100.0% | 480 | +100.0% | 0.00% | – |
| Q4 2013 | $3,000 | -89.3% | 240 | -89.6% | 0.00% | – |
| Q3 2013 | $28,000 | +16.7% | 2,307 | -2.1% | 0.00% | – |
| Q2 2013 | $24,000 | – | 2,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |